amfonelic acid has been researched along with Basal Ganglia Diseases in 1 studies
amfonelic acid: CNS-stimulant
Basal Ganglia Diseases: Diseases of the BASAL GANGLIA including the PUTAMEN; GLOBUS PALLIDUS; claustrum; AMYGDALA; and CAUDATE NUCLEUS. DYSKINESIAS (most notably involuntary movements and alterations of the rate of movement) represent the primary clinical manifestations of these disorders. Common etiologies include CEREBROVASCULAR DISORDERS; NEURODEGENERATIVE DISEASES; and CRANIOCEREBRAL TRAUMA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Waldmeier, PC | 1 |
| Huber, H | 1 |
| Heinrich, M | 1 |
| Stoecklin, K | 1 |
1 other study available for amfonelic acid and Basal Ganglia Diseases
| Article | Year |
|---|---|
Discrimination of neuroleptics by means of their interaction with amfonelic acid: an attempt to characterize the test.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antipsychotic Agents; Basal Ganglia Diseases; Corpus Striat | 1985 |